On January 30, 2019, Paradise Silicon Valley Intelligent Robot Industry Fund and China Industrial Founder Investment and US Nasdaq-listed company EKSO Bionics. formally signed a three-party joint venture agreement to jointly establish a Sino-US joint venture entity - Aikeso Intelligent Robot Co., Ltd. (hereinafter referred to as “joint venture company”) seeks close strategic cooperation in the field of anthropomorphic exoskeleton technology and develops the above-mentioned joint venture into a competitive manufacturer of wearable bionic exoskeleton products in the Chinese and foreign markets.

The joint venture will build a global technology-leading manufacturing facility with an annual manufacturing capacity of 2,000 wearable bionic exoskeleton products. The registered capital is RMB 780 million, of which the Paradise Silicon Valley Intelligent Robot Industry Fund contributes RMB 300 million in monetary terms, and U-Chuang Investment invests RMB 324 million in monetary terms. The US Ekso Bionics Company grants patent technology and proprietary technology for free. In a combined manner.

Ekso Bionics, the partner of the United States, is the world's top design and manufacturing enterprise for bionic exoskeleton robots. It is the first ossicular robot medical device company approved by the US FDA to develop and produce stroke and spinal cord injury patients. + Accepted) 28+38 US patents and licenses, 112+102 international patents and licenses. The company currently sells (including leasing) 354 clinical exoskeleton robots at 260 rehabilitation centers around the world. Ekso Bionics is a pioneer in the global exoskeleton robot industry and has industry experience and brand advantages unmatched by other competitors. It was launched on NASDAQ in August 2016 (NASDAQ: EKSO).

China Industrial Fangyou Investment has been strategically placed in the field of large health industry for many years, and has deepened various related industries such as fine chemicals, cosmetics, APIs, preparations, etc., and focused on rehabilitation medical equipment, pension real estate and other related industries, focusing on our company. The big health industry, one of the three major industries invested, fits perfectly. The signing of the contract marks the beginning of cooperation between the two sides to complement each other and jointly develop the medical rehabilitation industry.

The joint venture company will settle in Shaoxing Keqiao. Shaoxing Keqiao is the world's textile capital, and the textile printing and dyeing industry is its traditional advantageous industry. In recent years, around the construction of Hangzhou Dawan District, the national strategy of integrating into the core economic circle of the Yangtze River Delta, continue to increase efforts to recruit talents from around the world, attract investment, and strive to develop emerging industries such as smart manufacturing, medical information, rehabilitation and old-age care. As the administrator of the Keqiao District Government Industry Fund, Paradise Silicon Valley fully utilizes its own resource advantages to promote the landing of the joint venture company in Keqiao District, which will greatly assist the regional industry transformation and upgrading.

The achievement of the Sino-US tripartite trading cooperation is an innovative practice of Paradise Silicon Valley participating in international cooperation and industrial strategic layout. It is a successful attempt to focus on the large-scale health industry to achieve regional investment attraction. It not only proves the professional ability of Paradise Silicon Valley in the industry focus and financial transaction architecture design, but also reflects the integration ability in the integration of trading resources and production integration.